NCT06817980Recruiting
Disorders of the Sense of Self and Physical Activity
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
Schizophrenia (SZ) patients with metabolic syndrome, patients with vestibular syndrome, and patients with borderline personality disorder, would benefit from physical activity (PA). Yet patient adherence to PA is low, at least in the case of SZ. the investigators work and the literature lead the investigators to consider that, in addition to motivational aspects, disorders of the bodily sense of self could play a role in this lack of adherence. Simply walking involves visual movements related to the self, which must be distinguished from movements in the environment. This means a distinction between self and not-self. Furthermore, these movements are all the more difficult to distinguish as they may also result from the fact that hidden objects become visible as a result of our own movement. In all sense-of-self disorders can themselves affect physical training, and the investigators will measure them in the first stage. In the second stage, the investigators will apply a standard, risk-free PA protocol by walking (3x3 sessions of 30 min). the investigators will test the impact of physical training on the sense of self under different conditions, with one environment minimizing self-related movement, vs. 2 environments with a variable level of enrichment (i.e. hidden objects inducing more or less self-related movement). At the end of the protocol, the investigators will offer participants who wish to take part in an ancillary study, i.e. a walking session with mixed-reality goggles. These will superimpose a luminous flux on the periphery of the visual field. According to results obtained in the laboratory, this flux could restore sensory mechanisms impaired in schizophrenia. the investigators will use these glasses in the most difficult condition for the patient, and verify their impact.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 168 (estimated)
- First submitted
- 16 Dec 2024
- Start date
- 11 Aug 2025
- Primary completion date
- 1 Sept 2028
- Lead sponsor
- University Hospital, Strasbourg, France
- Diseases
- Schizophrenia
- NCT number
- NCT06817980
What you commit to
- Study type: Interventional
- Planned participants: 168
- From 11 Aug 2025 to the primary completion date, 1 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject in exclusion period (determined by a previous or current study)
Other illness
- History likely to affect cerebral anatomy or to be linked to an abnormality (neonatal suffering, neurosurgical operation, comitiality, stroke...)
- \- Substance use disorders (as defined by DSM-IV TR)
- 3D vision disorders as measured by the Wirt stereotest (depth perception at a disparity of at least 80'' arc)
- Movement perception disorders (correct movement discrimination in less than 75% of trials (cf. § V-2.2)
- History of general anaesthesia in the 3 months preceding the study
- History of neurological disease
- History of major psychiatric pathology with current psychotropic medication (i.e., antidepressant, thymoregulator, antipsychotic)
Other
- Criteria common to all participants:
- Serious or unstabilized somatic pathology (including cardiovascular)
- Presence of joint pain, likely to worsen after exercise
- Impossibility of giving the subject informed information (subject in emergency situation)
- Pregnancy declared by patient
- Breast-feeding
- Subject hospitalized
- Subject under court protection
Who the study is looking for
- Criteria common to all participants:
- Men or women aged 18 to 60 inclusive
- Subject affiliated to a health insurance scheme, beneficiary or beneficiary's beneficiary
- Able to understand the aims and risks of the research, and to give informed consent
- Visual acuity \> 0.7 on the Freiburg Vision Test (Bach 1996) due to the use of visual equipment
- BMI (body mass index) \< 40 (due to cardiovascular risk).
- Patient-specific criteria:
- With schizophrenia: criteria for schizophrenia as defined in the DSMV (American Psychiatric Association, 2015)
- With borderline personality disorder: criteria for borderline personality disorder as defined in the DSMV (American Psychiatric Association, 2015)
- With vestibular disorders: peripheral vestibular disorders established after otolaryngological examination
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service de psychiatrie Coordinator of this site? Confirm its status | Strasbourg | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.